 TORONTO and HOUSTON, Feb. 17, 2021 GLOBE NEWSWIRE -- Medicenna Therapeutics Corp. Medicenna or the Company NASDAQ: MDNA TSX: MDNA, a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, President, CEO and Chairman of the Board of Medicenna, will present a corporate overview at the 10th Annual Leerink Global Healthcare Conference on Friday, February 26th, 2021, at 3:00 PM ET. 